7 completed, 2 unknown. 6 Not applicable, 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Unknown 2 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Ondine Biomedical Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada Nasal antimicrobial photodisinfection therapy - Surgical Site Infections, Infections | Not applicable | Completed | Ondine Biomedical Inc. | 401 | 2026-01-13 | 2026-09-15 |
| Steriwave ICU Pilot Study Antimicrobial photodynamic therapy (aPDT) nasal decolonization device - Ventilator Acquired Pneumonia, Hospital Acquired Pneumonia | Not applicable | Completed | Fraser Health | 227 | 2025-03-18 | 2026-03-05 |
| Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections nasal antimicrobial photodisinfection therapy - Surgical Site Infections, Surgical Wound Infection | Phase 3 | Completed | Ondine Biomedical Inc. | 4787 | 2024-12-27 | 2026-09-15 |
| Preoperative Microbial Reduction of the Nasal Cavity With Antimicrobial Photodynamic Therapy (aPDT). activated Light Source (aPDT), non activated Light Source (Control) - Efficacy of Preoperative Microbial Reduction in the Nasal Cavity Using Antimicrobial Photodynamic Therapy (aPDT) | Not applicable | Unknown | University of Zurich | 208 | 2024-10-01 | 2024-08-26 |
| Red Light Photobiomodulation and Topical Disinfectants Methylene Blue Only, Chlorhexidine Gluconate Only, Methylene Blue + Chlorhexidine Gluconate - Healthcare Associated Infection, Nosocomial Infection | Phase 1 / Phase 2 | Completed | Ondine Biomedical Inc. | 28 | 2023-01-10 | 2023-04-04 |
| Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures methylene blue 0.01%/chlorhexidine gluconate 0.25% + light activation - Surgical Site Infections, Nosocomial Infection | Phase 2 | Completed | Ondine Biomedical Inc. | 322 | 2022-02-04 | 2022-08-22 |
| Photodynamic Therapy for COVID-19 Prevention Nasal Photodisinfection, Sham Comparator: Control - COVID-19 Respiratory Infection, SARS-CoV-2 Acute Respiratory Disease | Not applicable | Completed | Ondine Biomedical Inc. | 100 | 2021-12-20 | 2022-08-12 |
| Photodynamic Therapy Plus Root Debridement in Gum Disease Treatment V2 light activated dye photodynamic therapy (PDT) - Periodontitis | Not applicable | Completed | Sheffield Teaching Hospitals NHS Foundation Trust | 31 | 2017-10-13 | 2019-05-30 |
| Photodynamic Therapy for the Treatment of Chronic Rhinosinusitis Photodisinfection (antimicrobial photodynamic therapy, aPDT), Saline irrigation - Chronic Sinusitis | Not applicable | Unknown | Ondine Biomedical Inc. | 48 | 2013-05-01 | 2013-05-17 |
Surgical Wound Infection (4) · Staphylococcal Infections (3) · Cross Infection (2) · Infections (2) · COVID-19 (1) · Healthcare-Associated Pneumonia (1) · Paranasal Sinus Diseases (1) · Periodontitis (1) · Pneumonia, Ventilator-Associated (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Sinusitis (1)
Photochemotherapy (2) · 1-phenyl-3,3-dimethyltriazene (1) · Methylene Blue (1) · Phototherapy (1) · chlorhexidine gluconate (1)
Canada (3) · United States (3) · Spain (1) · United Kingdom (1)
Gareth Griffiths (1) · Harald Essig, Prof Dr Dr (1) · Josepmaria Argemi, MD (1) · Martin Desrosiers, MD (1) · Simon Sinclair, MD, PhD (1) · Stephen A. Thacker, MD (1) · Steven Reynolds (1)